
GRK6-IN-2
CAS No. 2677786-27-3
GRK6-IN-2( —— )
Catalog No. M35570 CAS No. 2677786-27-3
GRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 92 | Get Quote |
![]() ![]() |
10MG | 155 | Get Quote |
![]() ![]() |
25MG | 296 | Get Quote |
![]() ![]() |
50MG | 457 | Get Quote |
![]() ![]() |
100MG | 672 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGRK6-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionGRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma.
-
DescriptionGRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research of multiple myeloma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetGRK (GPCRK)
-
RecptorGRK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2677786-27-3
-
Formula Weight376.43
-
Molecular FormulaC21H21FN6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Methanol : ≥ 125 mg/mL (332.07 mM)DMSO : ≥ 100 mg/mL (265.65 mM)
-
SMILESCCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3ccccc23)n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Uehling DE, et al. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma [published correction appears in J Med Chem. 2022 Jan 13;65(1):886-887]. J Med Chem. 2021;64(15):11129-11147.?
molnova catalog



related products
-
PEN (human)
Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.
-
GRK6-IN-1
GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM, and has potential for study in multiple myeloma.
-
GRK2i
GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. Corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.